简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
02480.HK
LUZHU BIOTECH-B(02480.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 61.62 million, loss narrowed by 20.56% YoY
Tags:
LUZHU BIOTECH-B
02480.HK
loss narrowed
2026-08-26
LUZHU BIOTECH-B (02480.HK): Phase III Results of Shingles Vaccine LZ901 Published in Nature Communications, Overall Vaccine Efficacy of 91.6%
Tags:
LUZHU BIOTECH-B
02480.HK
R&D Progress
2026-08-09
Featured News
Research
Going Global Weekly Report: Innovative Drugs Win Dense FDA Clearances; SHEIN and Mech-Mind Lead the Hong Kong Listing Wave - 20260828
Research
HK Stock Connect Daily Report: SUNAC Jumps Over 10%, VGT Slips Nearly 13%, Expectations Grow for DIAGENS-B Inclusion in Stock Connect - 20260828
Finance
SIWI SCI & TECH (01202.HK): Terminates Possible Very Substantial Disposal of Subsidiary Interest via Public Listing
Finance
MOMENTUM FIN (01152.HK): Expects H1 Turnaround to Net Loss of Approximately HKD 3.2 Million
Research
HK shares ETFs Daily Report: Fintech Leads Again! Taiwan and Gold Miners Advance in Tandem as Leveraged ChiNext and STAR 50 Retreat Under Pressure - 20260828
Research
Shanghai-Shenzhen Stock Connect ETFs Daily Report: Chemical ETFs Lead Against the Tide! Semiconductor Equipment Names Slump Over 3% Broadly as Sector Rotation Accelerates - 20260828
Tech
Autonomous Driving Concept Stocks Watch | RoboSense (02498.HK): Afternoon Weakness, H1 LiDAR Shipments Hit 719,200 Units, Surge 169.6% YoY
ETF
Ishares Nasdaq 100 Index Etf (02834.HK): Up 0.21% Intraday at HK$567.40
ETF
Value Gold ETF (03081.HK): Up 0.18% Intraday, Turnover Rate at 0.70%
ETF
Csop Mag Seven Etf (03454.HK): Up 0.89% Intraday, Average Price at HK$11.333
Scan QR Code
Download App